Wellness startup Gutsy Health has secured a £300k investment to accelerate growth of its range of Gut Wealth digestive health supplements.
Gemma Stuart launched the business in 2022 following a 15-year battle with IBS.
Edinburgh-based Gutsy Health raised the money from Scottish angel investment syndicates Equity Gap and Apollo Informal Investments, and economic development agency Scottish Enterprise.
The funding will help the business scale the Gut Wealth brand’s UK presence, accelerate international growth and expand its product portfolio of digestive supplements.
Gutsy Health is aiming to drive wider retail distribution across pharmacies, health stores and national retailers for its flagship liquid supplement, and boost its e-commerce operation.
Gut Wealth’s products use a clinically studied postbiotic that the company claimed was “safe, stable and doesn’t require refrigeration”. It also sells targeted vitamins and minerals for overall digestive support.
“We’re helping thousands of people live freely from the pain and shame of gut ill health, so they aren’t held back from work, social plans or worrying what their gut is going to do next,” Stuart said.
“I created Gut Wealth from my own experience of irritable bowels, and, in 2026, I’ll be growing our team as we scale from our core direct-to-consumer sales into national retailers and international markets.
“This investment… means we can reach more people with our science-led digestive supplements that are simple to use and genuinely life-improving. People shouldn’t have to suffer in silence with bloating, cramping or those dreaded toilet dashes. Gut Wealth liquids and capsules make it easy to make a daily good-gut choice.”
Equity Gap MD Fraser Lusty added: “We’re seeing digestive health become one of the most urgent and underserved wellbeing challenges in the UK, and consumers are increasingly demanding solutions that are science-led, not trend-led.
“Gutsy Health is tapping directly into that shift. Gemma’s understanding of the market, her personal insight into the consumer struggle, and the quality of the science behind her products made this a compelling investment case. With new product development underway, Gut Wealth is well placed to become a leading UK player in digestive wellness.”
Apollo Informal Investments director Michiel Smith said: “The gut health supplement industry is expanding, with increasing consumer interest in the link between gut health, immunity, and overall wellbeing. Gut Wealth’s unique, science-led formula has received high praise from its customers online. We strongly believe in the company’s growth potential and are very excited to become a part of its journey.”
No comments yet